The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B contract pharmacy law. The law preserves 340B discounts for drugs dispensed at community pharmacies. 

The AHA also filed friend-of-the-court briefs in the Southern District of Mississippi prior to the court’s denial of the injunctions in July. The AHA has filed briefs in similar cases elsewhere, including in the U.S. Court of Appeals for the 8th Circuit, which upheld a similar law in Arkansas.
 
Joining AHA in the Nov. 15 filings were 340B Health, the Mississippi Hospital Association, the Rural Hospital Alliance and the American Society for Health-system Pharmacists.

Headline
The AHA Sept. 23 submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act). The…
Headline
As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the…
Headline
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1. Data…
Headline
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability and Integrity Now and for the Future…